Trial Profile
A PHASE II STUDY OF GW572016 LAPATINIBTM ON CELL PROLIFERATION IN HER-2/neu ErbB2 POSITIVE BREAST CANCER BEFORE SURGERY.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 31 May 2011 New trial record